Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Efficacy of MM005-Granulae as prophylaxis for nocturnal hypoglycemia in insulin treated Type 1 diabetic subjects. A double-blind, randomized, placebo-controlled phase II multi-center study in three parallel arms. - GLU-005
100 Clinical Results associated with Metcon Medicin AB
0 Patents (Medical) associated with Metcon Medicin AB
100 Deals associated with Metcon Medicin AB
100 Translational Medicine associated with Metcon Medicin AB